New Step by Step Map For ITD-1
Kantarjian et al53 assessed the efficacy and safety of dasatinib, as when compared with imatinib, for the very first-line procedure of CML-CP. Five hundred and nineteen clients with recently diagnosed CML-CP were being randomly assigned to get dasatinib at a dose of 100 mg the moment each day (259 sufferers) or imatinib at a dose of 400 mg the mome